首页> 外文OA文献 >Mechanism of dexamphetamine-induced mydriasis in the anaesthetized rat.
【2h】

Mechanism of dexamphetamine-induced mydriasis in the anaesthetized rat.

机译:右苯丙胺诱导麻醉大鼠瞳孔散大的机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

1. The effect of intravenous administration of dexamphetamine [+)-Amp) on rat pupil diameter was investigated. In all experiments, the vagosympathetic trunks were sectioned bilaterally at the cervical level. 2. In rats anaesthetized with urethane, (+)-Amp (0.1-0.3 mg kg-1, i.v.) produced a dose-related increase in pupil size. The mydriatic effects of (+)-Amp were evident immediately after administration. 3. Pretreatment with the alpha 2-adrenoceptor antagonists yohimbine (1.5 mg kg-1 i.v.) or idazoxan (0.5 mg kg-1, i.v.) blocked the pupillary response to (+)-Amp. Yohimbine caused about a 30 fold shift to the right in the dose-response curve whereas idazoxan almost completely abolished the mydriatic response to (+)-Amp. 4. In contrast, pretreatment with the alpha 1-adrenoceptor antagonist phenoxybenzamine (2 mg kg-1, i.v.), failed to alter significantly the pupillary response to (+)-Amp. 5. Depletion of central nervous system (CNS) monoamines with reserpine (5 mg kg-1, i.p.) and alpha-methyl-p-tyrosine (2 x 300 mg kg-1, i.p.) prevented the pupillary response to (+)-Amp. 6. The mydriatic effect of (+)-Amp was present only in preparations that had intact parasympathetic neural tone to the iris. Central preganglionic denervation of the oculomotor nerve abolished the mydriatic response of (+)-Amp. 7. These results indicate the (+)-Amp acts in the CNS to produce mydriasis in the anaesthetized rat by stimulating CNS postsynaptic alpha 2-adrenoceptors, findings that are consistent with the hypothesis that (+)-Amp acts predominantly as an indirect sympathomimetic agent to release endogenous stores of a monoaminergic neurotransmitter (perhaps noradrenaline).
机译:1.研究了静脉内注射右苯丙胺[+]-Amp)对大鼠瞳孔直径的影响。在所有实验中,均将交感神经干在颈部水平双侧切开。 2.在用氨基甲酸乙酯麻醉的大鼠中,(+)-Amp(0.1-0.3 mg kg-1,i.v.)使瞳孔大小与剂量有关。给药后立即可见(+)-Amp的散瞳作用。 3.用α2-肾上腺素受体拮抗剂育亨宾(1.5mg / kg-1,静脉内)或伊达唑烷(0.5mg / kg-1,静脉内)预处理阻断了瞳孔对(+)-Amp的反应。育亨宾在剂量反应曲线中导致向右移动约30倍,而伊达唑烷几乎完全消除了对(+)-Amp的散瞳反应。 4.相反,用α1-肾上腺素受体拮抗剂苯氧基苯甲胺(2mg kg-1,i.v。)的预处理不能显着改变对(+)-Amp的瞳孔反应。 5.中枢神经系统(CNS)单胺与利血平(5 mg kg-1,ip)和α-甲基-对-酪氨酸(2 x 300 mg kg-1,ip)的消耗阻止了瞳孔对(+)-放大器6.(+)-Amp的散瞳作用仅在对虹膜具有完整的副交感神经调的制剂中存在。动眼神经的中央神经节前神经支配消除了(+)-Amp的散瞳反应。 7.这些结果表明,(+)-Amp通过刺激CNS突触后α2-肾上腺素能受体在麻醉大鼠中产生瞳孔散大,这一发现与(+)-Amp主要起间接拟交感神经作用的假设相符。释放单胺能神经递质(也许去甲肾上腺素)的内源性储存的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号